Individual and Family Therapy for Children With Anxiety Disorders - Full Text View

Sponsored by:	National Institute of Mental Health (NIMH)
Information provided by:	National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:	NCT00081406

Purpose

The purpose of this study is to compare three treatments to determine which is most effective in reducing anxiety in children.

Condition	Intervention	Phase
Anxiety	Behavioral: Individual Child CBT Behavioral: Family CBT Behavioral: Education/Support/Attention	Phase II Phase III

MedlinePlus related topics: Anxiety

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title:	Child and Family Therapy for Anxiety-Disordered Youth

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:	150
Study Start Date:	July 2000

Detailed Description:

Children and their parents will complete a comprehensive diagnostic assessment to determine eligibility. The assessment will include an individual diagnostic interview with the child, interviews with the parents, and written observations of the child from family members and teachers. Participants will then be randomly assigned to receive individual cognitive behavioral therapy (ICBT), family CBT (FCBT), or education/support/attention (ESA) for 5 months. Children in the ICBT group will meet individually with a therapist. In the FCBT and ESA treatment groups, children and their parents will meet weekly with a therapist.

At the end of treatment and 1 year following treatment completion, families will complete another assessment to determine the effectiveness of each treatment at reducing short- and long-term anxiety symptoms in their children.

Eligibility

Ages Eligible for Study:	9 Years to 13 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Child with DSM-IV criteria for separation anxiety disorder, social phobia, or generalized anxiety disorder

Exclusion Criteria for Child Participants:

IQ less than 80
Current use of anti-anxiety or antidepressant medications
Psychotic symptoms
Child and/or parent is non-English speaking

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00081406

Locations

United States, Pennsylvania
Temple University Child and Adolescent Anxiety Disorders Clinic
Philadelphia, Pennsylvania, United States, 19122

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

More Information

Web site for Child and Adolescent Anxiety Disorders Clinic at Temple University This link exits the ClinicalTrials.gov site

Publications:

Kendall PC. Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol. 1994 Feb;62(1):100-10.

Kendall PC, Flannery-Schroeder E, Panichelli-Mindel SM, Southam-Gerow M, Henin A, Warman M. Therapy for youths with anxiety disorders: a second randomized clinical trial. J Consult Clin Psychol. 1997 Jun;65(3):366-80.

Study ID Numbers:	R01 MH59087, DSIR CT-S
Study First Received:	April 9, 2004
Last Updated:	November 18, 2005
ClinicalTrials.gov Identifier:	NCT00081406
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Anxiety Disorders

ClinicalTrials.gov processed this record on January 16, 2009